Skip to main content
Premium Trial:

Request an Annual Quote

John Radak, Paul Landers, Matthew Robin, Carl Severinghaus, Thomas Bachmann

Point-of-care diagnostics maker Quidel announced this week that John Radak has been named CFO of the firm, succeeding Paul Landers. Radak joins Quidel from Invitrogen, where he served as vice president and chief accounting officer since 2003.
 

 
Swiss compounds research company Tecan last month said its board of directors has appointed and  to its group executive committee.
 
Robin will be responsible for the company’s liquid-handling and robotics business, which is currently being managed by CEO Thomas Bachmann. Robin previously was CEO of medical technology company .
 
Severinghaus worked previously with Beckman Coulter and the American Monitor Corporation, and the and has 15 years experience working at Tecan.
 
In his new position he will manage the company’s direct sales organization.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.